This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Technologies and Applications Digital Week
September 27 - 28, 2022
2-day free-to-attend webcast series
Book
Menu
Book

Neil Bodie
DVM, CEO at Paradigm Immunotherapeutics
Speaker

Agenda Sessions

  • Design of a Chimeric ACE-2/Fc-Silent Fusion Protein with Ultrahigh Affinity and Neutralizing Capacity for SARS-CoV-2 Variants

    , 11:00am
    View Session

At this event

Prev
Next
Nicola Bonzanni
Chief Product Officer
ENPICOM

See Neil at Antibody Technologies and Applications Digital Week

Book